Frozen Versus Fresh Corneal Carriers for the Boston KPro Type I Donor Carriers
NCT ID: NCT01950598
Last Updated: 2021-01-28
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
37 participants
INTERVENTIONAL
2013-09-30
2020-11-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Corneal transplantation is typically performed using fresh, transparent corneas. With KPro surgery, the corneal transplant only serves as a carrier to suture the KPro in place. The cornea used in KPro surgery does not need to be clear like a normal transplant. Frozen corneal tissue can be used to repair the cornea in cases of emergency but the tissue is not transparent and does not allow good vision. We hypothesize that frozen grafts are equivalent as fresh grafts when used as carrier for the KPro.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Corneal Collagen Crosslinking to Increase the Resistance of the Support Graft of the KPro Type I Against Corneal Melting
NCT03041883
Photorefractive Keratectomy and Corneal Cross-linking in Keratoconus
NCT02189447
Study to Evaluate the Clinical Safety and Performance of the CorNeat KPro for Treatment of Corneal Blindness
NCT05694247
Isolated Bowman Layer Graft for Reducing and Stabilizing Advanced Keratoconus
NCT01686906
Epi Off Versus Epi on Corneal Collagen Cross-linking in Keratoconus Patients
NCT03598634
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
During KPro surgery, the KPro needs to be incorporated into a corneal graft before it is sutured to the patient's cornea. The corneal graft serves as a support to the KPro and helps to re-establish vision. The corneas typically used as carriers for the KPro are fresh corneas provided through donors. These fresh corneas are also used in traditional corneal transplantation, without KPro implantation.
Due to shortage of fresh corneas in the province of Quebec, this project is interested in evaluating if corneas that have been previously frozen can act as carriers to the KPro. The frozen corneas cannot be used in traditional corneal transplantation surgery because they are not transparent. However, they can act as a support to the KPro, as in this case, it is the KPro and not the corneal graft that re-establishes vision. The use of frozen corneas for KPro surgery has the potential to improve access to corneal donor tissue and improve the wait-times for KPro surgery.
37 patients were be recruited from the Centre Hospitalier de l'Université de Montréal (CHUM), Notre-Dame Hospital between October 2008 and November 2009. Participants were divided into 2 groups: the first group will receive a KPro in a fresh corneal carrier graft while the second group will receive a KPro in a frozen carrier graft. The use of a fresh or frozen corneal graft depended on the availability of fresh tissue on the morning of surgery. 19 patients received a fresh carrier graft and 18 received a frozen carrier graft.
Patients were followed on postoperative day 1, week 1 and 2, month 1, 3 and 6 and every 1 to 3 months thereafter up to 2 years. At each follow-up visit, a complete ophthalmological examination was performed, including best-corrected Snellen visual acuity and slit lamp assessment for leaks, tissue necrosis, melts, extrusion, inflammation, retroprosthetic membrane formation and infectious endophthalmitis.
The current study aims re-consent patients previously enrolled in this study to prospectively evaluate the long-term outcomes of KPro surgery using either a fresh or frozen carrier graft. IRB approval was obtained from the CHUM. Written informed consent from the concerned patients will be obtained for this extension study during their routine visits at the CHUM Ophthalmology department.
Patients in this study will continue their routine follow-up at the frequency determined by their surgeon, which may vary from every 3 to 6 months.
Outcome measures include surgical feasibility, level of preoperative and postoperative visual acuity (VA), retention of the device and complications as stated above. Outcomes will be compared at 5 and 10 years.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Fresh carrier graft for KPro
KPro implanted using fresh cornea, preserved in optisol GS
Boston KPro type I - fresh graft
Boston KPro mounted on fresh corneal carrier graft for implantation
Frozen carrier graft for KPro
KPro implanted using frozen cornea, which was supplied as a whole globe cryopreserved at -80°C in gramicidin 0.025 mg/mL and polymyxin B sulfate 10 000 U/mL ophthalmic solution.
Boston KPro type I surgery - frozen graft
Boston KPro mounted on frozen corneal carrier graft for implantation
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Boston KPro type I - fresh graft
Boston KPro mounted on fresh corneal carrier graft for implantation
Boston KPro type I surgery - frozen graft
Boston KPro mounted on frozen corneal carrier graft for implantation
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Boston KPro type I indicated
* history, slit-lamp findings and B-scan do not suggest endstage glaucoma or significant posterior segment disease
* Able to provide informed consent for study inclusion
* Sufficiently healthy to undergo surgery and a vigorous post-operative follow-up course
* Able to administer eye medications or have a care-giver able and willing to do the same
* Corneal blindness with poor prognosis for survival of a traditional penetrating keratoplasty
Exclusion Criteria
* History, slit-lamp findings and B-scan suggest endstage glaucoma or significant posterior segment disease
* Not sufficiently healthy to undergo surgery and a vigorous post-operative follow-up course
* Unable to administer eye medication or does not have a care-giver willing to do the same
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Fonds de recherche en ophtalmologie de l'Université de Montréal
OTHER
Marie-Claude Robert
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Marie-Claude Robert
MD, FRSCS
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Mona Harissi-Dagher, M.D.
Role: PRINCIPAL_INVESTIGATOR
CHUM - Hôpital Notre-Dame
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Centre Hospitalier de l'Université de Montréal
Montreal, Quebec, Canada
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Robert MC, Biernacki K, Harissi-Dagher M. Boston keratoprosthesis type 1 surgery: use of frozen versus fresh corneal donor carriers. Cornea. 2012 Apr;31(4):339-45. doi: 10.1097/ICO.0b013e31823e6110.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
FvF 08.275
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.